1. Home
  2. CDP vs XENE Comparison

CDP vs XENE Comparison

Compare CDP & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

HOLD

Current Price

$30.82

Market Cap

3.4B

Sector

Real Estate

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$40.07

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDP
XENE
Founded
1988
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CDP
XENE
Price
$30.82
$40.07
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$32.86
$54.09
AVG Volume (30 Days)
1.1M
999.9K
Earning Date
02-05-2026
02-26-2026
Dividend Yield
3.96%
N/A
EPS Growth
9.45
N/A
EPS
1.32
N/A
Revenue
$752,757,000.00
$7,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$23.34
N/A
Revenue Growth
0.43
N/A
52 Week Low
$23.92
$26.74
52 Week High
$31.24
$46.60

Technical Indicators

Market Signals
Indicator
CDP
XENE
Relative Strength Index (RSI) 71.73 39.60
Support Level $29.23 $39.98
Resistance Level $29.86 $42.14
Average True Range (ATR) 0.64 1.92
MACD 0.29 -0.37
Stochastic Oscillator 98.82 1.41

Price Performance

Historical Comparison
CDP
XENE

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: